Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits and suddenly, a molecule makes a promising new medicine.

Diarrhea Diarrhea was the most common adverse reaction in two randomized, double-blind, placebo-controlled trials of IBS-C. Severe diarrhea was reported in 2.5% of IBSRELA-treated patients. If severe ...

Ironwood Pharmaceuticals is downgraded from a 'Buy' to a 'Sell' due to pipeline setbacks and declining LINZESS sales. Click ...

Equillium (EQ) remains a 'Hold' as it advances EQ504 for ulcerative colitis, with phase 1 trial initiation targeted for mid-2026. Company's Multi-Cytokine Platform enables selective cytokine targeting ...

A 20-year-old miniature horse presenting with colic was found to have three separate intestinal obstructions during emergency ...

Company produces thorough reference testing on Antibody Drug Conjugates, showing high correlation with clinical liver and intestinal toxicity and side effects SAN DIEGO, Feb. 11, 2026 (GLOBE NEWSWIRE) ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Small intestinal microbial ...

Utility of ctDNA in early switch of first-line mFOLFIRINOX in metastatic pancreatic ductal adenocarcinoma (mPDAC). This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers ...

Small intestine cancer is rare, with adenocarcinomas being the most common type, often occurring in the duodenum. Diagnosis involves imaging, endoscopy, and biopsy, with staging determined by the TNM ...

In this White Paper, MatTek, now part of Sartorius, details a highly differentiated 3D small-intestine tissue model that uses primary human stem cells to provide a more accurate alternative to animal ...